Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001140361-21-027544
Filing Date
2021-08-09
Accepted
2021-08-09 16:03:01
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 ny20000272x1_424b5.htm 424B5 748862
2 logo_biocryst2a.jpg GRAPHIC 48001
3 logo_biocryst2ax1.jpg GRAPHIC 66123
  Complete submission text file 0001140361-21-027544.txt   906752
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-253719 | Film No.: 211156385
SIC: 2836 Biological Products, (No Diagnostic Substances)